layout.fixed.naaccr.doc.naaccr18.ajccTnmPostTherapyN.html Maven / Gradle / Ivy
Item #
Length
Source of Standard
Year Implemented
Version Implemented
Year Retired
Version Retired
Column #
1022
15
AJCC
2018
18
1237 - 1251
NAACCR XML: Tumor.ajccTnmPostTherapyN
Description
Detailed site-specific codes for the postneoadjuvant therapy nodes (N) as defined by AJCC.
Clinical, pathological, and postneoadjuvant therapy stage data are given three separate areas in the NAACCR Data Exchange Record Layout.
Rationale
CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.
Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of lymph node metastasis of the tumor known known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and planned postneoadjuvant therapy surgical resection.
Codes (in addition to those published in the AJCC Cancer Staging Manual)
88
Not applicable, no code assigned for this case in the current AJCC Staging Manual.
Blank
This field is left blank if no information at all is available to code this item.
Note: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT
STORE manual for specifications for codes and data entry rules.